FDA Sticks Breakthrough Tag on GlaxoSmithKline's Blood Cancer Drug Post author:Sam Post published:November 1, 2017 Post category:BioPharma GSK2857916 is an anti B-cell maturation agent (BCMA) monoclonal antibody-drug conjugate. Source: BioSpace You Might Also Like Teva Backpedals on 6,000 Job Cuts, Says Figure is Too High March 22, 2017 Nanobiotix Half Year Results For The Six Months Ended 30 June 2017 August 31, 2017 Sanofi Appoints Executive Vice President Diabetes & Cardiovascular October 1, 2017
